Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients

Annals of Pharmacotherapy

Volumn 40, Issue 11, 2006, Pages 1966-1973

  Lacasse, Hélène ^a   Perreault, Marc M ^b,c   Williamson, David R ^c,d  

^a Pharmaprix Jean François Guévin   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Antipsychotics; Delirium

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORPROMAZINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; COCHRANE LIBRARY; DELIRIUM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; DYSTONIA; EMBASE; EXTRAPYRAMIDAL SYNDROME; FEMALE; HOSPITAL ASSOCIATED DELIRIUM; HOSPITAL PATIENT; HUMAN; HYPOKINESIA; MALE; MEDLINE; MUSCLE RIGIDITY; PARKINSONISM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCINFO; RATING SCALE; REVIEW; SALIVATION DISORDER; SCISEARCH; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; TREMOR;

ANTIPSYCHOTIC AGENTS; DELIRIUM; HALOPERIDOL; HOSPITAL DEPARTMENTS; HOSPITALIZATION; HUMANS; SURGERY DEPARTMENT, HOSPITAL;

EID: 33751001646     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H241     Document Type: Review

References (49)

1. Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry 2004;75:362-7. DOI 10.1136/jnnp.2003.023366
2. Skrobik YK. An overview of delirium in the critical care setting. Geriatr Aging 2003;6:30-5.
3. Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med 2001;22:115-26. DOI 10.1055/s-2001-13826
4. Bergeron N, Skrobik Y, Dubois MJ. Delirium in critically ill patients. Crit Care 2002;6:181-2. DOI 10.1186/cc1482
5. Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712-8. DOI 10.1200/JCO.2005.05.140
6. Brown TM, Boyle MF. Delirium. BMJ 2002;325:644-7. DOI 10.1136/bmj.325.7365.644
7. Marcantonio ER, Flacker JM, Michaels M, Resnick NM. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000;48:618-24.
8. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004;32:955-62. DOI 10.1097/01.CCM.0000119429.16055.92
9. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001;27:1892-900. DOI 10.1007/s00134-001-H32-2
10. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-62. DOI 10.1001/jama.291.14.1753
11. McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc 2003;51:591-8. DOI 10.1034/j.1600-0579.2003.00201.x
12. Ely EW, Stephens RK, Jackson JC, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004;32:106-12. DOI 10.1097/01.CCM.0000098033.94737.84
13. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-76.
14. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001;49:516-22.
15. Ryan CJ. Optimising management of delirium. Placebo controlled trials of pharmacological treatments are needed (letter). BMJ 2001;322:1602. DOI 10.1136/bmj.322.7302.1602
16. Dial S. Acute delirium in the intensive care unit. Clin Pulm Med 2002;9:260-6.
17. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41. DOI 10.1097/00003246-200201000-00020
18. Milbrandt EB, Kersten A, Kong L, et al. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005;33:226-9. DOI 10.1097/01.CCM.0000150743.16005.9A
19. Hassaballa HA, Balk RA. Torsade de pointes associated with the administration of intravenous haloperidol. Am J Ther 2003;10:58-60. DOI 10.1097/00045391200301000-00013
20. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999;156:1-20. DOI 10.1176/appi.ajp. l58.1.1
21. Schwartz TL, Masand PS. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002;43:171-4. DOI 10.1176/appi.psy.433. 171
22. Chalmers TC, Smith H Jr, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:31-49. DOI 10.1016/01972456(81)90056-8
23. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900. DOI 10.1016/80140-6736(99)04149-5
24. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62-73. DOI 10.1016/0197-2456(94)00031-W
25. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. DOI 10.1016/0197-2456(95)00134-4
26. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington, DC: American Psychiatric Association, 1987.
27. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97. DOI 10.1016/0165-1781(88)90037-6
28. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-42.
29. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997;13:128-37. DOI 10.1016/80885-3924(96)00316-8
30. McCusker J, Cole M, Bellavance F, Primeau F. Reliability and validity of a new measure of severity of delirium. Int Psychogeriatr 1998;10:421-33. DOI 10.1017/S1041610298005493
31. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990;113:941-8.
32. Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res 2005;76:247-65.
33. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:11-9.
34. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-7.
35. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301.
36. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-9. DOI 10.1007/S00134-003-2117-0
37. Lee KU, Won WY, Lee HK, et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005;20:311-4. DOI 10.1097/00004850-200511000-00005
38. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
39. Kim KS, Pae CU, Chae JH, Bahk WM, Jun T. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001;55:515-9.
40. Kim KY, Bader GM, Kotlyar V, Gropper D. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003;16:29-31.
41. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002;43:175-82. DOI 10.1176/appi.psy.43.3.175
42. Horikawa N, Yamazaki T, Miyamoto K, et al. Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003;25:289-92. DOI 10.1016/80163-8343(03)00024-0
43. Liu CY, Juang YY, Liang HY, Lin NC, Yeh EK. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004;19:165-8. DOI 10.1097/00004850-200405000-00008
44. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005;53:1658-66. DOI 10.1111/j.1532-5415.2005.53503.x
45. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-6. DOI 10.1097/00000542-200601000-00005
46. Parthasarathy S, Tobin MJ. Sleep in the intensive care unit. Intensive Care Med 2004;30:197-206. DOI 10.1007/s00134-003-2030-6
47. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002;359:515-9. DOI 10.1016/80140-6736(02) 07683-3
48. Menza MA, Murray GB, Holmes VF, Rafuls WA. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988;17:238-41.
49. Wright P, Lindborg SR, Birkett M, et al. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Can J Psychiatry 2003;48:716-21.